{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:53:53Z","timestamp":1787997233176,"version":"build-2784847793"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81870489"],"award-info":[{"award-number":["81870489"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Key Clinical Research Program of Southern Medical University","award":["LC2019ZD002"],"award-info":[{"award-number":["LC2019ZD002"]}]},{"name":"the Nature and Science Foundation of China","award":["81770765"],"award-info":[{"award-number":["81770765"]}]},{"name":"the Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University","award":["2017J013"],"award-info":[{"award-number":["2017J013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Relationship between serum phosphorus time in range and mortality risk in peritoneal dialysis (PD) patients remains uncertain. We aimed to evaluate the association between serum phosphorus time in range and all-cause mortality in Chinese PD population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a multicenter, retrospective, cohort study of 1,915 patients collected from January 2008 to October 2020 in 4 Chinese centers. Serum phosphorus time in range was estimated as the months during the first year that a patient\u2019s serum phosphorus level was within the target range (defined as 1.13\u20131.78 mmol\/L). The primary outcome was all-cause mortality. The secondary outcomes were cardiovascular (CV) mortality and PD withdrawal. Cox proportional hazards regression model with comprehensive adjustments was used to assess the association.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The primary outcome occurred in 249 (13.0%) PD patients over a median follow-up of 28 months. Overall, the serum phosphorus time in range was negatively associated with all-cause mortality (per 3-month increments, adjusted HR [aHR], 0.83; 95%CI: 0.75\u20130.92), CV mortality (per 3-month increments, aHR, 0.87; 95%CI: 0.77\u20130.99), and PD withdrawal (per 3-month increments, aHR, 0.89; 95%CI: 0.83\u20130.95). Competing-risk model showed that the relationship of serum phosphorus time in range with all-cause mortality remained stable. None of the variables including demographics, history of diabetes and CV disease, as well as several PD-related and clinical indicators modified this association.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PD patients with longer serum phosphorus time in range in the first year was negatively associated with all-cause mortality and CV mortality. Our findings highlight the importance of maintaining serum phosphorus levels within 1.13\u20131.78 mmol\/L for PD patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03395-9","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T15:01:46Z","timestamp":1711724506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Longer serum phosphorus time in range associated with lower mortality risk among peritoneal dialysis patients: a multicenter retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhihao","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisha","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianrui","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfa","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaozhong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"issue":"9","key":"3395_CR1","first-page":"2513","volume":"21","author":"M Noordzij","year":"2006","unstructured":"Noordzij M, Korevaar JC, Bos WJ, Boeschoten EW, Dekker FW, Bossuyt PM, et al. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association -. Eur Ren Association. 2006;21(9):2513\u201320.","journal-title":"Eur Ren Association"},{"issue":"1","key":"3395_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nrneph.2016.164","volume":"13","author":"MG Vervloet","year":"2017","unstructured":"Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D. The role of phosphate in Kidney Disease. Nat Rev Nephrol. 2017;13(1):27\u201338.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"3395_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1542-4758.2007.00190.x","volume":"11","author":"N Kimata","year":"2007","unstructured":"Kimata N, Albert JM, Akiba T, Yamazaki S, Kawaguchi T, Fukuhara S, et al. Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study. Hemodial Int. 2007;11(3):340\u20138.","journal-title":"Hemodial Int"},{"issue":"3","key":"3395_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","volume":"52","author":"F Tentori","year":"2008","unstructured":"Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2008;52(3):519\u201330.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"3395_CR5","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1681\/ASN.2014050472","volume":"26","author":"MB Rivara","year":"2015","unstructured":"Rivara MB, Ravel V, Kalantar-Zadeh K, Streja E, Lau WL, Nissenson AR, et al. Uncorrected and albumin-corrected calcium, Phosphorus, and mortality in patients undergoing maintenance Dialysis. J Am Soc Nephrol. 2015;26(7):1671\u201381.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"3395_CR6","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/jama.2011.308","volume":"305","author":"SC Palmer","year":"2011","unstructured":"Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and Cardiovascular Disease in individuals with chronic Kidney Disease: a systematic review and meta-analysis. JAMA. 2011;305(11):1119\u201327.","journal-title":"JAMA"},{"issue":"1","key":"3395_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1525-139X.2009.00676.x","volume":"23","author":"F Tentori","year":"2010","unstructured":"Tentori F. Mineral and bone disorder and outcomes in hemodialysis patients: results from the DOPPS. Semin Dial. 2010;23(1):10\u20134.","journal-title":"Semin Dial"},{"issue":"3","key":"3395_CR8","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","volume":"67","author":"EW Young","year":"2005","unstructured":"Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, et al. Predictors and consequences of altered mineral metabolism: the Dialysis outcomes and practice patterns study. Kidney Int. 2005;67(3):1179\u201387.","journal-title":"Kidney Int"},{"issue":"9","key":"3395_CR9","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","volume":"30","author":"JL Fern\u00e1ndez-Mart\u00edn","year":"2015","unstructured":"Fern\u00e1ndez-Mart\u00edn JL, Mart\u00ednez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G, et al. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant. 2015;30(9):1542\u201351.","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"3395_CR10","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/nep.13535","volume":"24","author":"M Wu","year":"2019","unstructured":"Wu M, Wu H, Huang X, Ye H, Huang F, Yu X, et al. Associations between serum mineral metabolism parameters and mortality in patients on peritoneal dialysis. Nephrol (Carlton). 2019;24(11):1148\u201356.","journal-title":"Nephrol (Carlton)"},{"key":"3395_CR11","doi-asserted-by":"publisher","first-page":"32359","DOI":"10.1038\/srep32359","volume":"6","author":"X Liu","year":"2016","unstructured":"Liu X, Huang R, Wu H, Wu J, Wang J, Yu X, et al. Patient characteristics and risk factors of early and late death in incident peritoneal dialysis patients. Sci Rep. 2016;6:32359.","journal-title":"Sci Rep"},{"issue":"5","key":"3395_CR12","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1053\/j.ajkd.2005.08.013","volume":"46","author":"M Noordzij","year":"2005","unstructured":"Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT. The Kidney Disease outcomes Quality Initiative (K\/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2005;46(5):925\u201332.","journal-title":"Am J Kidney Diseases: Official J Natl Kidney Foundation"},{"issue":"11","key":"3395_CR13","doi-asserted-by":"publisher","first-page":"603","DOI":"10.11622\/smedj.2015195","volume":"57","author":"SH Chuang","year":"2016","unstructured":"Chuang SH, Wong HC, Vathsala A, Lee E, How PP. Prevalence of chronic kidney disease-mineral and bone disorder in incident peritoneal dialysis patients and its association with short-term outcomes. Singap Med J. 2016;57(11):603\u20139.","journal-title":"Singap Med J"},{"key":"3395_CR14","doi-asserted-by":"publisher","first-page":"760394","DOI":"10.3389\/fmed.2021.760394","volume":"8","author":"N Huang","year":"2021","unstructured":"Huang N, Li H, Fan L, Zhou Q, Fu D, Guo L, et al. Serum phosphorus and albumin in patients undergoing peritoneal Dialysis: Interaction and Association with Mortality. Front Med (Lausanne). 2021;8:760394.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"3395_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000118847","volume":"26","author":"M Noordzij","year":"2008","unstructured":"Noordzij M, Korevaar JC, Dekker FW, Boeschoten EW, Bos WJ, Krediet RT, et al. Mineral metabolism and mortality in dialysis patients: a reassessment of the K\/DOQI guideline. Blood Purif. 2008;26(3):231\u20137.","journal-title":"Blood Purif"},{"issue":"4","key":"3395_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/08860220801964236","volume":"30","author":"PJ Phelan","year":"2008","unstructured":"Phelan PJ, O\u2019Kelly P, Walshe JJ, Conlon PJ. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients. Ren Fail. 2008;30(4):423\u20139.","journal-title":"Ren Fail"},{"issue":"2","key":"3395_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3109\/0886022X.2011.646808","volume":"34","author":"SH Kang","year":"2012","unstructured":"Kang SH, Cho KH, Park JW, Yoon KW, Do JY. Risk factors for mortality in stable peritoneal dialysis patients. Ren Fail. 2012;34(2):149\u201354.","journal-title":"Ren Fail"},{"issue":"1","key":"3395_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41598-017-00080-4","volume":"7","author":"CT Liu","year":"2017","unstructured":"Liu CT, Lin YC, Lin YC, Kao CC, Chen HH, Hsu CC, et al. Roles of serum calcium, phosphorus, PTH and ALP on Mortality in Peritoneal Dialysis patients: a Nationwide, Population-based Longitudinal Study using TWRDS 2005\u20132012. Sci Rep. 2017;7(1):33.","journal-title":"Sci Rep"},{"issue":"1","key":"3395_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/0886022X.2022.2041438","volume":"44","author":"L Chen","year":"2022","unstructured":"Chen L, Tang X, Zheng H, Wang H, Xia P, Wang Y, et al. Optimal targets of chronic kidney disease-mineral and bone disorder markers for Chinese patients with maintenance peritoneal dialysis: a single-center retrospective cohort study. Ren Fail. 2022;44(1):336\u201345.","journal-title":"Ren Fail"},{"issue":"8","key":"3395_CR20","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose Monitoring Data Interpretation: recommendations from the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593\u2013603.","journal-title":"Diabetes Care"},{"issue":"5","key":"3395_CR21","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2215\/CJN.01060308","volume":"3","author":"MD Danese","year":"2008","unstructured":"Danese MD, Belozeroff V, Smirnakis K, Rothman KJ. Consistent control of mineral and bone disorder in incident hemodialysis patients. Clin J Am Soc Nephrology: CJASN. 2008;3(5):1423\u20139.","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"issue":"3","key":"3395_CR22","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/j.ajkd.2010.08.037","volume":"57","author":"N Tangri","year":"2011","unstructured":"Tangri N, Wagner M, Griffith JL, Miskulin DC, Hodsman A, Ansell D, et al. Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2011;57(3):415\u201321.","journal-title":"Am J Kidney Diseases: Official J Natl Kidney Foundation"},{"issue":"5","key":"3395_CR23","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.jacl.2021.06.005","volume":"15","author":"J Yu","year":"2021","unstructured":"Yu J, Xia X, Lin T, Huang N, Qiu Y, Yang X, et al. Non-high-density lipoprotein cholesterol and mortality among peritoneal dialysis patients. J Clin Lipidol. 2021;15(5):732\u201342.","journal-title":"J Clin Lipidol"},{"issue":"2","key":"3395_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.numecd.2020.10.005","volume":"31","author":"R Liu","year":"2021","unstructured":"Liu R, Peng Y, Wu H, Diao X, Ye H, Huang X, et al. Uric acid to high-density lipoprotein cholesterol ratio predicts cardiovascular mortality in patients on peritoneal dialysis. Nutr Metab Cardiovasc Dis. 2021;31(2):561\u20139.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"3395_CR25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1159\/000507785","volume":"6","author":"N Gong","year":"2020","unstructured":"Gong N, Xiao Z, Zhang F, Zhong X, He Y, Yi Z, et al. Duration of Serum Phosphorus Control Associated with overall mortality in patients undergoing peritoneal Dialysis. Kidney Dis (Basel). 2020;6(6):434\u201343.","journal-title":"Kidney Dis (Basel)"},{"issue":"2","key":"3395_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrneph.2016.181","volume":"13","author":"PK Li","year":"2017","unstructured":"Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90\u2013103.","journal-title":"Nat Rev Nephrol"},{"issue":"Suppl 2","key":"3395_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3747\/pdi.2017.00283","volume":"38","author":"X Yu","year":"2018","unstructured":"Yu X, Chen J, Ni Z, Chen N, Chen M, Dong J, et al. Number of daily peritoneal Dialysis exchanges and mortality risk in a Chinese Population. Perit Dial Int. 2018;38(Suppl 2):53\u2013S63.","journal-title":"Perit Dial Int"},{"issue":"4 Suppl 3","key":"3395_CR28","first-page":"1","volume":"42","author":"K\/DOQI clinical","year":"2003","unstructured":"K\/DOQI clinical. Practice guidelines for bone metabolism and Disease in chronic Kidney Disease. Am J Kidney Diseases: Official J Natl Kidney Foundation. 2003;42(4 Suppl 3):1\u2013201.","journal-title":"Am J Kidney Diseases: Official J Natl Kidney Foundation"},{"issue":"3 Suppl 2","key":"3395_CR29","first-page":"67","volume":"30","author":"NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy","year":"1997","unstructured":"NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. Natl Kidney Foundation Am J Kidney Dis. 1997;30(3 Suppl 2):67\u2013136.","journal-title":"Natl Kidney Foundation Am J Kidney Dis"},{"issue":"5","key":"3395_CR30","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1053\/j.ajkd.2005.08.013","volume":"46","author":"M Noordzij","year":"2005","unstructured":"Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT, et al. The Kidney Disease outcomes Quality Initiative (K\/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis. 2005;46(5):925\u201332.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"3395_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al. Executive summary of the 2017 KDIGO chronic kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what\u2019s changed and why it matters. Kidney Int. 2017;92(1):26\u201336.","journal-title":"Kidney Int"},{"issue":"11","key":"3395_CR32","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1681\/ASN.2016010112","volume":"27","author":"R Mehrotra","year":"2016","unstructured":"Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal Dialysis. J Am Soc Nephrology: JASN. 2016;27(11):3238\u201352.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"10","key":"3395_CR33","doi-asserted-by":"publisher","first-page":"e0185853","DOI":"10.1371\/journal.pone.0185853","volume":"12","author":"JE Lee","year":"2017","unstructured":"Lee JE, Lim JH, Jang HM, Kim YS, Kang SW, Yang CW, et al. Low serum phosphate as an Independent predictor of increased infection-related mortality in dialysis patients: a prospective multicenter cohort study. PLoS ONE. 2017;12(10):e0185853.","journal-title":"PLoS ONE"},{"issue":"3","key":"3395_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.arcmed.2013.01.008","volume":"44","author":"R Paniagua","year":"2013","unstructured":"Paniagua R, Ventura MD, \u00c1vila-D\u00edaz M, Hinojosa-Heredia H, M\u00e9ndez-Duran A, Cisneros A, et al. Reaching targets for mineral metabolism clinical practice guidelines and its impact on outcomes among Mexican chronic dialysis patients. Arch Med Res. 2013;44(3):229\u201334.","journal-title":"Arch Med Res"},{"key":"3395_CR35","unstructured":"KDIGO clinical practice guideline for the. Diagnosis, evaluation, prevention, and treatment of chronic kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Supplement. 2009(113):S1\u2013130."},{"issue":"2","key":"3395_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1590\/2175-8239-jbn-2020-0040","volume":"43","author":"C Truyts","year":"2021","unstructured":"Truyts C, Custodio M, Pecoit-Filho R, Moraes TP, Jorgetti V. Cardiovascular mortality in peritoneal dialysis: the impact of mineral disorders. J Bras Nefrol. 2021;43(2):182\u201390.","journal-title":"J Bras Nefrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03395-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03395-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03395-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T15:02:34Z","timestamp":1711724554000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03395-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3395"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03395-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,29]]},"assertion":[{"value":"15 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Research Ethics Committee of Nanfang Hospital, Guangzhou, China (ethics number NFEC-2019-213). The Research Ethics Committee of Nanfang Hospital, Southern Medical University waived patient informed consent because this study was retrospective (ethics number NFEC-2019-213).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}